지속적 신대체요법(CRRT) 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2031년)

Persistence Market Research has recently released a comprehensive report on the worldwide market for Continuous Renal Replacement Therapy (CRRT). The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global CRRT market from 2024 to 2031.

Key Insights:

• CRRT Market Size (2024E): US$ 2.46 Bn
• Projected Market Value (2031F): US$ 2.79 Bn
• Global Market Growth Rate (CAGR 2024 to 2031): 8.7%

CRRT Market - Report Scope:

Continuous Renal Replacement Therapy (CRRT) plays a crucial role in the treatment of critically ill patients suffering from acute kidney injury (AKI) or chronic kidney conditions, particularly in intensive care units (ICUs). CRRT offers a more gradual and continuous method of removing toxins and excess fluids from the body, improving patient comfort and outcomes. The CRRT market caters to hospitals, clinics, and healthcare settings offering a range of CRRT machines, filters, and consumables. Market growth is driven by increasing incidence rates of kidney diseases, a growing geriatric population, and advancements in CRRT technologies, enhancing treatment efficacy and patient safety.

Market Growth Drivers:

The global CRRT market is propelled by several key factors, including the rising prevalence of kidney diseases, particularly acute kidney injury (AKI), which leads to an increased demand for CRRT devices. The growing geriatric population, which is more prone to renal failure, further contributes to the demand for CRRT solutions. Technological advancements, such as the development of more efficient CRRT machines, improved membranes, and automated systems, enhance treatment outcomes, making CRRT more accessible and effective. Additionally, the increasing awareness among healthcare providers regarding the benefits of continuous therapy over intermittent methods continues to expand the market.

Market Restraints:

Despite promising growth prospects, the CRRT market faces challenges related to high operational costs and limited reimbursement policies in certain regions. The high cost of CRRT devices and consumables can limit access to therapy, especially in resource-constrained healthcare systems. Furthermore, the complexity of CRRT machines and the need for specialized training for healthcare professionals to operate these devices present barriers to widespread adoption. In addition, there are concerns regarding the risk of complications, such as infection or clotting, associated with long-term CRRT use, which can restrict its utilization in some patient populations.

Market Opportunities:

The CRRT market presents significant growth opportunities driven by technological innovations, demographic trends, and healthcare infrastructure improvements. The integration of artificial intelligence (AI) and machine learning (ML) into CRRT systems is opening up new avenues for personalized treatment, improving clinical outcomes, and optimizing therapy management. Additionally, the expanding application of CRRT in regions with emerging healthcare markets, such as Asia Pacific and Latin America, presents untapped opportunities for growth. Strategic partnerships, research, and development into more cost-effective and efficient CRRT solutions are key to capitalizing on these opportunities.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the CRRT market globally?
• How are technological advancements reshaping the CRRT market?
• Which patient populations and healthcare settings are driving CRRT adoption?
• Who are the key players contributing to the CRRT market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global CRRT market?

Competitive Intelligence and Business Strategy:

Leading players in the global CRRT market, including Baxter International, Fresenius Medical Care, and Nipro Corporation, focus on product innovation, partnerships, and expanding their market reach to strengthen their competitive edge. These companies invest in R&D to develop advanced CRRT machines, improved filter technologies, and user-friendly systems that enhance patient care. Collaborations with hospitals, research institutions, and regulatory bodies facilitate market entry and promote the adoption of CRRT technologies. Additionally, companies are placing emphasis on the development of systems with improved connectivity and remote monitoring capabilities to cater to the growing demand for telemedicine and patient-centric care.

Key Companies Profiled:

• Baxter International Inc.
• Fresenius Medical Care AG & Co. KGaA
• Nipro Corporation
• B. Braun Melsungen AG
• Asahi Kasei Medical Co., Ltd.
• Medtronic PLC
• Gambro (now part of Baxter)
• Jafron Biomedical Co., Ltd.
• Toray Medical Co., Ltd.

Continuous Renal Replacement Therapy Market Segmentation

By Product

• System
• Consumables

By Modality

• Slow Continuous Ultra-Filtration (SCUF)
• Continuous Venovenous Hemofiltration (CVVH)
• Continuous Venovenous Hemodialysis (CVVHD)
• Continuous Venovenous Hemodiafiltration (CVVHDF)

By End User

• Hospitals
• Dialysis Clinics
• Ambulatory Surgical Centers

By Region

• North America
• Latin America
• Europe
• South Asia and Oceania
• East Asia
• Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Continuous Renal Replacement Therapy (CRRT) Market Snapshot, 2024-2031
• 1.2. Market Opportunity Assessment, 2024-2031, US$ Bn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global Sectorial Outlook
  • 2.3.2. Global GDP Growth Outlook
  • 2.3.3. Global Healthcare Spending Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Regulatory Landscape
• 3.2. Value Chain Analysis
• 3.3. Key Deals and Mergers
• 3.4. PESTLE Analysis
• 3.5. Porter's Five Force Analysis

4. Global Continuous Renal Replacement Therapy (CRRT) Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 4.1. Key Highlights
  • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
  • 4.1.2. Absolute $ Opportunity
• 4.2. Market Size (US$ Bn) Analysis and Forecast
  • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
  • 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2023-2031
• 4.3. Global Continuous Renal Replacement Therapy (CRRT) Market Outlook: Product
  • 4.3.1. Introduction / Key Findings
  • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Product, 2019-2023
  • 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
    • 4.3.3.1. System
    • 4.3.3.2. Consumables
• 4.4. Market Attractiveness Analysis: Product
• 4.5. Global Continuous Renal Replacement Therapy (CRRT) Market Outlook: Modality
  • 4.5.1. Introduction / Key Findings
  • 4.5.2. Historical Market Size (US$ Bn) Analysis, By Modality, 2019-2023
  • 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2024-2031
    • 4.5.3.1. Slow Continuous Ultra-Filtration (SCUF)
    • 4.5.3.2. Continuous Venovenous Hemofiltration (CVVH)
    • 4.5.3.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 4.5.3.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
• 4.6. Market Attractiveness Analysis: Modality
• 4.7. Global Continuous Renal Replacement Therapy (CRRT) Market Outlook: End User
  • 4.7.1. Introduction / Key Findings
  • 4.7.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
  • 4.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 4.7.3.1. Hospitals
    • 4.7.3.2. Dialysis Clinics
    • 4.7.3.3. Ambulatory Surgical Centers
    • 4.7.3.4. Others
• 4.8. Market Attractiveness Analysis: End User

5. Global Continuous Renal Replacement Therapy (CRRT) Market Outlook: Region

• 5.1. Key Highlights
• 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2023
• 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024-2031
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. East Asia
  • 5.3.4. South Asia and Oceania
  • 5.3.5. Latin America
  • 5.3.6. Middle East & Africa
• 5.4. Market Attractiveness Analysis: Region

6. North America Continuous Renal Replacement Therapy (CRRT) Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
  • 6.2.1. By Country
  • 6.2.2. By Product
  • 6.2.3. By Modality
  • 6.2.4. By End User
• 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
  • 6.3.1. U.S.
  • 6.3.2. Canada
• 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
  • 6.4.1. System
  • 6.4.2. Consumables
• 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2024-2031
  • 6.5.1. Slow Continuous Ultra-Filtration (SCUF)
  • 6.5.2. Continuous Venovenous Hemofiltration (CVVH)
  • 6.5.3. Continuous Venovenous Hemodialysis (CVVHD)
  • 6.5.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
• 6.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
  • 6.6.1. Hospitals
  • 6.6.2. Dialysis Clinics
  • 6.6.3. Ambulatory Surgical Centers
  • 6.6.4. Others
• 6.7. Market Attractiveness Analysis

7. Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
  • 7.2.1. By Country
  • 7.2.2. By Product
  • 7.2.3. By Modality
  • 7.2.4. By End User
• 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
  • 7.3.1. Germany
  • 7.3.2. France
  • 7.3.3. U.K.
  • 7.3.4. Italy
  • 7.3.5. Spain
  • 7.3.6. Russia
  • 7.3.7. Turkey
  • 7.3.8. Rest of Europe
• 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
  • 7.4.1. System
  • 7.4.2. Consumables
• 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2024-2031
  • 7.5.1. Slow Continuous Ultra-Filtration (SCUF)
  • 7.5.2. Continuous Venovenous Hemofiltration (CVVH)
  • 7.5.3. Continuous Venovenous Hemodialysis (CVVHD)
  • 7.5.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
• 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
  • 7.6.1. Hospitals
  • 7.6.2. Dialysis Clinics
  • 7.6.3. Ambulatory Surgical Centers
  • 7.6.4. Others
• 7.7. Market Attractiveness Analysis

8. East Asia Continuous Renal Replacement Therapy (CRRT) Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
  • 8.2.1. By Country
  • 8.2.2. By Product
  • 8.2.3. By Modality
  • 8.2.4. By End User
• 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
  • 8.3.1. China
  • 8.3.2. Japan
  • 8.3.3. South Korea
• 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
  • 8.4.1. System
  • 8.4.2. Consumables
• 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2024-2031
  • 8.5.1. Slow Continuous Ultra-Filtration (SCUF)
  • 8.5.2. Continuous Venovenous Hemofiltration (CVVH)
  • 8.5.3. Continuous Venovenous Hemodialysis (CVVHD)
  • 8.5.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
• 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
  • 8.6.1. Hospitals
  • 8.6.2. Dialysis Clinics
  • 8.6.3. Ambulatory Surgical Centers
  • 8.6.4. Others
• 8.7. Market Attractiveness Analysis

9. South Asia & Oceania Continuous Renal Replacement Therapy (CRRT) Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
  • 9.2.1. By Country
  • 9.2.2. By Product
  • 9.2.3. By Modality
  • 9.2.4. By End User
• 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
  • 9.3.1. India
  • 9.3.2. Southeast Asia
  • 9.3.3. ANZ
  • 9.3.4. Rest of South Asia & Oceania
• 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
  • 9.4.1. System
  • 9.4.2. Consumables
• 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2024-2031
  • 9.5.1. Slow Continuous Ultra-Filtration (SCUF)
  • 9.5.2. Continuous Venovenous Hemofiltration (CVVH)
  • 9.5.3. Continuous Venovenous Hemodialysis (CVVHD)
  • 9.5.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
• 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
  • 9.6.1. Hospitals
  • 9.6.2. Dialysis Clinics
  • 9.6.3. Ambulatory Surgical Centers
  • 9.6.4. Others
• 9.7. Market Attractiveness Analysis

10. Latin America Continuous Renal Replacement Therapy (CRRT) Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
  • 10.2.1. By Country
  • 10.2.2. By Product
  • 10.2.3. By Modality
  • 10.2.4. By End User
• 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
  • 10.3.1. Brazil
  • 10.3.2. Mexico
  • 10.3.3. Rest of Latin America
• 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
  • 10.4.1. System
  • 10.4.2. Consumables
• 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2024-2031
  • 10.5.1. Slow Continuous Ultra-Filtration (SCUF)
  • 10.5.2. Continuous Venovenous Hemofiltration (CVVH)
  • 10.5.3. Continuous Venovenous Hemodialysis (CVVHD)
  • 10.5.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
• 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
  • 10.6.1. Hospitals
  • 10.6.2. Dialysis Clinics
  • 10.6.3. Ambulatory Surgical Centers
  • 10.6.4. Others
• 10.7. Market Attractiveness Analysis

11. Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
  • 11.2.1. By Country
  • 11.2.2. By Product
  • 11.2.3. By Modality
  • 11.2.4. By End User
• 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
  • 11.3.1. GCC Countries
  • 11.3.2. Egypt
  • 11.3.3. South Africa
  • 11.3.4. Northern Africa
  • 11.3.5. Rest of Middle East & Africa
• 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
  • 11.4.1. System
  • 11.4.2. Consumables
• 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2024-2031
  • 11.5.1. Slow Continuous Ultra-Filtration (SCUF)
  • 11.5.2. Continuous Venovenous Hemofiltration (CVVH)
  • 11.5.3. Continuous Venovenous Hemodialysis (CVVHD)
  • 11.5.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
• 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
  • 11.6.1. Hospitals
  • 11.6.2. Dialysis Clinics
  • 11.6.3. Ambulatory Surgical Centers
  • 11.6.4. Others
• 11.7. Market Attractiveness Analysis

12. Competition Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. Market Structure
  • 12.2.1. Competition Intensity Mapping By Market
  • 12.2.2. Competition Dashboard
• 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 12.3.1. Fresenius Medical Care
    • 12.3.1.1. Overview
    • 12.3.1.2. Segments and Products
    • 12.3.1.3. Key Financials
    • 12.3.1.4. Market Developments
    • 12.3.1.5. Market Strategy
  • 12.3.2. B. Braun Melsungen AG
  • 12.3.3. Kawasaki Medical
  • 12.3.4. Medtronic
  • 12.3.5. Asahi Kasei Medical
  • 12.3.6. Nikkiso Co., Ltd.
  • 12.3.7. JMS Co., Ltd.
  • 12.3.8. Dialysis Systems
  • 12.3.9. Thermo Fisher Scientific
  • 12.3.10. CytoSorbents Corporation

13. Appendix

• 13.1. Research Methodology
• 13.2. Research Assumptions
• 13.3. Acronyms and Abbreviations